0057 APOE4 Genotype and Blunted Homeostatic Sleep EEG in Young Adolescents: An Early Marker of Alzheimer’s Disease Risk?

Abstract Introduction The e4 allele of the Apolipoprotein (APOE4) contributes to sleep disturbances and increases risk for Alzheimer’s Disease (AD). When in life these risks emerge is unknown. Specifically, whether APOE4 status alters sleep in adolescents has not been investigated. We present a study of sleep physiology under rested and homeostatic challenged conditions in healthy adolescents whose genetic risk for AD is heightened by APOE4 carrier status. Methods Thirty-seven cognitively healthy youth (9.6-15.8 [12.2±1.5] years; 18M) were genotyped as high (n=11; 9.6-13.1 [11.6±1.3] years; 3M) or low (n=26, 9.6-15.8 [12.4±1.6] years; 15M) risk for AD (APOE4 carrier [≥1 allele] vs. non-carrier [0 alleles]). After 1-week of 9.5h sleep stabilization and a laboratory adaptation night, participants slept in the laboratory for two consecutive nights: baseline (9.5h TIB) followed by wake-extension (4.5h delayed bedtime; 5h TIB). PSG included 9 EEGs (F3,Fz,F4,C3,Cz,C4,P3,P4,O1,O2). After staging (R&K) and artifact-rejection, we computed relative delta (.5-4 Hz) power in NREM (stages 2-4) across the first three sleep cycles. A linear mixed-effects model (covariates: age, sex; random intercepts: subject, EEG-channel) examined gene-risk (high vs. low), sleep condition (baseline vs. wake-extension) and NREM cycle . Results We identified expected main-effects of cycle (i.e., delta decayed over time; F(2,1804.8)=672.1; p<.001) and condition (i.e., delta increased after wake-extension (F(1,1808.3)=118.6; p<.001). However, we detected a significant interaction of gene-risk, sleep condition, and NREM cycle (F(2,1804.3)=3.3, p=.039); i.e., the time-course of delta power was moderated by gene-risk. Wake extension for high-risk youth showed a blunted decay of delta between cycles 1 and 2 (b=.043; p<.001) relative to baseline; this effect was not found for the low-risk group (b=.01; p=.19) where delta decay did not differ between sleep conditions. Conclusion These data indicate that genetic risk of Alzheimer’s Disease may affect the homeostatic response of NREM delta power in healthy youth. Whether these differences, when coupled with the routine experience of adolescent insufficient sleep, contribute to lifelong risk (e.g., altered glymphatic clearance or amyloid-beta accumulation) remains unknown. Our findings offer novel evidence of a sleep signature for dementia risk decades before cognitive decline, opening unprecedented opportunities for prevention. Support (if any) P20GM103645 (Project Leader:JMS); Zimmerman Innovation Award (JMS, MAC); P20GM139743 (PI:MAC)

Authors

Institutions

Publication Details

Journal
SLEEP
Published
2026-05-01
DOI
https://doi.org/10.1093/sleep/zsag091.0057
Primary Topic
Sleep and related disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

0057 APOE4 Genotype and Blunted Homeostatic Sleep EEG in Young Adolescents: An Early Marker of Alzheimer’s Disease Risk?

John McGeary, Mary Carskadon, Jared Saletin, Caroline Gredvig-Ardito et al.
SLEEP
Sleep and related disorders
article

0057 APOE4 Genotype and Blunted Homeostatic Sleep EEG in Young Adolescents: An Early Marker of Alzheimer’s Disease Risk?

John McGeary, Mary Carskadon, Jared Saletin, Caroline Gredvig-Ardito, Gina Mason, Claire Mayew Sherman, Athene Lee, Jayne Clark, Hwamee Oh, Bridget Berman
article en

Abstract

Abstract Introduction The e4 allele of the Apolipoprotein (APOE4) contributes to sleep disturbances and increases risk for Alzheimer’s Disease (AD). When in life these risks emerge is unknown. Specifically, whether APOE4 status alters sleep in adolescents has not been investigated. We present a study of sleep physiology under rested and homeostatic challenged conditions in healthy adolescents whose genetic risk for AD is heightened by APOE4 carrier status. Methods Thirty-seven cognitively healthy youth (9.6-15.8 [12.2±1.5] years; 18M) were genotyped as high (n=11; 9.6-13.1 [11.6±1.3] years; 3M) or low (n=26, 9.6-15.8 [12.4±1.6] years; 15M) risk for AD (APOE4 carrier [≥1 allele] vs. non-carrier [0 alleles]). After 1-week of 9.5h sleep stabilization and a laboratory adaptation night, participants slept in the laboratory for two consecutive nights: baseline (9.5h TIB) followed by wake-extension (4.5h delayed bedtime; 5h TIB). PSG included 9 EEGs (F3,Fz,F4,C3,Cz,C4,P3,P4,O1,O2). After staging (R&K) and artifact-rejection, we computed relative delta (.5-4 Hz) power in NREM (stages 2-4) across the first three sleep cycles. A linear mixed-effects model (covariates: age, sex; random intercepts: subject, EEG-channel) examined gene-risk (high vs. low), sleep condition (baseline vs. wake-extension) and NREM cycle . Results We identified expected main-effects of cycle (i.e., delta decayed over time; F(2,1804.8)=672.1; p<.001) and condition (i.e., delta increased after wake-extension (F(1,1808.3)=118.6; p<.001). However, we detected a significant interaction of gene-risk, sleep condition, and NREM cycle (F(2,1804.3)=3.3, p=.039); i.e., the time-course of delta power was moderated by gene-risk. Wake extension for high-risk youth showed a blunted decay of delta between cycles 1 and 2 (b=.043; p<.001) relative to baseline; this effect was not found for the low-risk group (b=.01; p=.19) where delta decay did not differ between sleep conditions. Conclusion These data indicate that genetic risk of Alzheimer’s Disease may affect the homeostatic response of NREM delta power in healthy youth. Whether these differences, when coupled with the routine experience of adolescent insufficient sleep, contribute to lifelong risk (e.g., altered glymphatic clearance or amyloid-beta accumulation) remains unknown. Our findings offer novel evidence of a sleep signature for dementia risk decades before cognitive decline, opening unprecedented opportunities for prevention. Support (if any) P20GM103645 (Project Leader:JMS); Zimmerman Innovation Award (JMS, MAC); P20GM139743 (PI:MAC)

SLEEPVol. 49(Supplement_1)
Brown University (US), Bradley Hospital (US)
Good health and well-being
Openalex Percentile: Top 5%
Sleep and related disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.